|
Volumn 133, Issue 4, 2002, Pages 475-483
|
Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
FOMIVIRSEN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DOSE RESPONSE;
DRUG SAFETY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETINITIS;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS RETINITIS;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INJECTIONS;
MALE;
OPHTHALMIC SOLUTIONS;
PROSPECTIVE STUDIES;
THIONUCLEOTIDES;
VIRUS ACTIVATION;
VITREOUS BODY;
|
EID: 0036211366
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9394(02)01326-0 Document Type: Article |
Times cited : (64)
|
References (28)
|